Theo J C van Berkel Selected Research

Theo J C van Berkel Research Topics

Disease

36	Atherosclerosis 03/2022 - 04/2002
16	Atherosclerotic Plaque (Atheroma) 10/2019 - 04/2002
12	Inflammation (Inflammations) 03/2022 - 11/2002
5	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 01/2007
4	Carotid Stenosis (Carotid Artery Stenosis) 03/2022 - 09/2003
4	Acute Coronary Syndrome 01/2012 - 09/2008
3	Hemorrhage 05/2013 - 01/2010
3	Rupture 09/2008 - 04/2002
2	Obesity 01/2020 - 03/2009
2	Hepatocellular Carcinoma (Hepatoma) 01/2013 - 05/2002
2	Vascular System Injuries 09/2012 - 02/2011
2	Pathologic Constriction (Stenosis) 02/2011 - 02/2004
2	Hypercholesterolemia 01/2011 - 01/2006
2	Neoplasms (Cancer) 04/2010 - 05/2002
2	Carcinogenesis 05/2002 - 05/2002
1	Disease Progression 03/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Hypertriglyceridemia 01/2020
1	Leukemia 10/2019
1	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 01/2013
1	Wounds and Injuries (Trauma) 01/2012
1	Acute-Phase Reaction 02/2011
1	Body Weight (Weight, Body) 02/2011
1	Abdominal Aortic Aneurysm 07/2010
1	Aneurysm (Aneurysms) 07/2010
1	Unstable Angina 04/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2010
1	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2009

Drug/Important Bio-Agent (IBA)

9	Apolipoproteins E (ApoE)IBA 01/2013 - 09/2003
8	LDL Receptors (LDL Receptor)IBA 11/2013 - 12/2005
6	LipidsIBA 03/2022 - 08/2009
6	ApolipoproteinsIBA 08/2013 - 04/2002
5	Scavenger Receptors (Scavenger Receptor)IBA 01/2020 - 10/2005
4	CholesterolIBA 11/2013 - 01/2006
4	P-SelectinIBA 01/2005 - 11/2002
3	oxidized low density lipoproteinIBA 11/2013 - 01/2007
3	Pharmaceutical PreparationsIBA 10/2013 - 06/2005
3	Peptides (Polypeptides)IBA 10/2013 - 11/2002
3	Lipoproteins (Lipoprotein)IBA 02/2010 - 12/2005
2	Contrast MediaIBA 03/2022 - 08/2013
2	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 03/2022 - 08/2013
2	LigandsIBA 11/2013 - 10/2013
2	Immunoglobulin M (IgM)IBA 11/2013 - 01/2007
2	lysophosphatidic acidIBA 05/2013 - 06/2010
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 06/2010
2	ChemokinesIBA 01/2012 - 09/2008
2	DNA (Deoxyribonucleic Acid)IBA 06/2009 - 09/2007
2	Chemokine ReceptorsIBA 02/2008 - 12/2005
2	CalcineurinIBA 01/2007 - 07/2006
2	baysilon (polydimethylsiloxane)IBA 12/2005 - 04/2002
2	Protein Isoforms (Isoforms)IBA 05/2002 - 05/2002
1	Ferrosoferric Oxide (Magnetite)FDA Link 03/2022
1	ferric oxide (iron oxide)IBA 03/2022
1	HDL LipoproteinsIBA 01/2020
1	Phospholipid Transfer ProteinsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Apoptosis Regulatory ProteinsIBA 10/2019
1	src-Family KinasesIBA 08/2015
1	Dietary CholesterolIBA 11/2013
1	CD40 Ligand (CD40L)IBA 10/2013
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 05/2013
1	LysophospholipidsIBA 05/2013
1	Mast Cell StabilizersIBA 05/2013
1	Phosphotransferases (Kinase)IBA 01/2013
1	CollagenIBA 09/2012
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2012
1	Adenosine A2B ReceptorIBA 09/2012
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012
1	Calcineurin InhibitorsIBA 01/2012
1	Granzymes (Granzyme)IBA 01/2012
1	Chemokine CCL5IBA 01/2012
1	SerpinsIBA 01/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2011
1	Growth Differentiation Factor 15IBA 02/2011
1	Insulin (Novolin)FDA Link 02/2011
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2011
1	Atorvastatin (Lipitor)FDA Link 02/2011
1	CytokinesIBA 01/2011
1	A-Form DNA (A-DNA)IBA 01/2011
1	Interleukin-15 (Interleukin 15)IBA 01/2011
1	RO 5066852IBA 01/2011
1	Chymases (Chymase)IBA 01/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2010
1	Small Interfering RNA (siRNA)IBA 07/2010
1	MicroRNAs (MicroRNA)IBA 04/2010
1	Biomarkers (Surrogate Marker)IBA 04/2010
1	OvalbuminIBA 02/2010
1	AntigensIBA 02/2010
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2010
1	Substance PIBA 01/2010
1	NeuropeptidesIBA 01/2010
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2010

Therapy/Procedure

6	Therapeutics 01/2012 - 04/2002
1	Endarterectomy (Thromboendarterectomy) 03/2022
1	Injections 03/2022
1	Intravenous Injections 08/2013
1	Oral Administration 01/2011
1	Immunomodulation 02/2010
1	Transplantation 09/2009